Clazosentan in Aneurysmal Subarachnoid Hemorrhage (CONSCIOUS-3)
This study has been terminated.
(Lack of efficacy data from the Phase 3 clinical study (AC-054-301; CONSCIOUS-2))
First Posted: July 15, 2009
Last Update Posted: May 15, 2015
Information provided by (Responsible Party):
No Study Results Posted on ClinicalTrials.gov for this Study
|Study Status:||This study has been terminated.|
|Study Completion Date:||January 2011|
|Primary Completion Date:||October 2010 (Final data collection date for primary outcome measure)|
|Certification or Request for Extension to Delay Results Submission:||March 22, 2011|
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Macdonald RL, Higashida RT, Keller E, Mayer SA, Molyneux A, Raabe A, Vajkoczy P, Wanke I, Bach D, Frey A, Nowbakht P, Roux S, Kassell N. Randomized trial of clazosentan in patients with aneurysmal subarachnoid hemorrhage undergoing endovascular coiling. Stroke. 2012 Jun;43(6):1463-9. doi: 10.1161/STROKEAHA.111.648980. Epub 2012 Mar 8. Erratum in: Stroke. 2012 Jul;43(7):e68.